About Viyash
Viyash is a company based in Hyderabad (India) founded in 2019 by Srihari Raju Kalidindi and Haribabu Bodepudi.. Viyash has raised $120.02 million across 2 funding rounds from investors including The Carlyle Group, Veeramachaneni Sirisha and Bodepudi Vls Kumari. Viyash has completed 1 acquisition, including Symed. Viyash offers products and services including Finished Dosages, APIs, and Intermediates. Viyash operates in a competitive market with competitors including Inventys, Blue Jet Healthcare, Ami organics, Aparna Pharmaceuticals and DUDE CHEM, among others.
- Headquarter Hyderabad, India
- Founders Srihari Raju Kalidindi, Haribabu Bodepudi
- Stage Minicorn
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Viyash Life Sciences Private Limited
- Date of Incorporation 21 Feb, 2019
- Jurisdiction Hyderabad, Telangana, India
-
Annual Revenue
$159.42 M (USD)11.63as on Mar 31, 2024
-
Net Profit
$-994.63 K (USD)94.99as on Mar 31, 2024
-
EBITDA
$16.96 M (USD)1688.45as on Mar 31, 2024
-
Total Equity Funding
$120.02 M (USD)
in 2 rounds
-
Latest Funding Round
$111.96 M (USD), Angel Round
Jul 05, 2021
-
Investors
The Carlyle Group
& 38 more
-
Employee Count
Employee Count
- Investments & Acquisitions
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Viyash
Viyash offers a comprehensive portfolio of products and services, including Finished Dosages, APIs, and Intermediates. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Manufactured formulations for animal health and treatment applications
Essential components for pharmaceutical drug production processes
Precursors used in synthesizing active pharmaceutical ingredients
Unlock access to complete
Funding Insights of Viyash
Viyash has successfully raised a total of $120.02M across 2 strategic funding rounds. The most recent funding activity was a Angel Round round of $111.96 million completed in July 2021. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 2
- Last Round Angel Round — $112.0M
-
First Round
First Round
(07 Mar 2020)
- Investors Count 39
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Angel Round - Viyash | Valuation | Veeramachaneni Sirisha , Bodepudi Vls Kumari | |
| Mar, 2020 | Amount | Angel Round - Viyash | Valuation | Dayakar Reddy Mallu , Gsr Anjaneyulu |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Viyash
Viyash has secured backing from 39 investors, including angel and venture fund investors. Prominent investors backing the company include The Carlyle Group, Veeramachaneni Sirisha and Bodepudi Vls Kumari. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Private equity investments are directed toward multiple sectors.
|
Founded Year | Domain | Location | |
|
VS
Veeramachaneni Sirisha |
-
|
Founded Year | Domain | Location |
|
BV
Bodepudi Vls Kumari |
-
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Viyash
Viyash has strategically engaged in corporate development activities, having acquired 1 company. Notable acquisitions include Symed. These strategic investments and acquisitions demonstrate the company's commitment to growth through portfolio expansion, market consolidation, technology integration, and strategic partnerships that enhance competitive positioning and drive long-term value creation.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
APIs are manufactured and drug development services are provided.
|
1997 |
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
OVO is recognized as a smart digital payment application.
|
2017 | ||||
|
Bionic investment advisor platform
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 |
Financial Statements - Viyash
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Viyash Comparisons
Competitors of Viyash
Viyash operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Inventys, Blue Jet Healthcare, Ami organics, Aparna Pharmaceuticals and DUDE CHEM, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Actives, advanced intermediates, and specialty chemicals are custom manufactured.
|
|
| domain | founded_year | HQ Location |
CDMO focused on manufacturing, supplier, and development of intermediates & APIs
|
|
| domain | founded_year | HQ Location |
Advanced API intermediates are manufactured for pharmaceutical use.
|
|
| domain | founded_year | HQ Location |
API intermediates are manufactured by Aparna Pharmaceuticals as a CDMO.
|
|
| domain | founded_year | HQ Location |
CDMO focused on manufacturing of APIs and intermediates
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Viyash
Frequently Asked Questions about Viyash
When was Viyash founded?
Viyash was founded in 2019 and raised its 1st funding round 1 year after it was founded.
Where is Viyash located?
Viyash is headquartered in Hyderabad, India. It is registered at Hyderabad, Telangana, India.
Who is the current CEO of Viyash?
Haribabu Bodepudi is the current CEO of Viyash. They have also founded this company.
Is Viyash a funded company?
Viyash is a funded company, having raised a total of $120.02M across 2 funding rounds to date. The company's 1st funding round was a Angel Round of $8.07M, raised on Mar 07, 2020.
What is the annual revenue of Viyash?
Annual revenue of Viyash is $159.42M as on Mar 31, 2024.
What does Viyash do?
Viyash was established in 2019 in Hyderabad, India, as a contract development and manufacturing organization. Focus is placed on the production of active pharmaceutical ingredients and intermediates within the pharmaceutical sector. Operations are managed from the companys base in India, with leadership provided by co-founders Haribabu Bodepudi as CEO and Srihari Raju Kalidindi as COO. Services encompass development and manufacturing for pharmaceutical needs.
Who are the top competitors of Viyash?
Viyash's top competitors include Inventys, Blue Jet Healthcare and Ami organics.
What products or services does Viyash offer?
Viyash offers Finished Dosages, APIs, and Intermediates.
How many acquisitions has Viyash made?
Viyash has made 1 acquisition, including Symed.
Who are Viyash's investors?
Viyash has 39 investors. Key investors include The Carlyle Group, Veeramachaneni Sirisha, Bodepudi Vls Kumari, Kota Krishna Rao, and Haribabu Bodepudi.
What is Viyash's valuation?
The valuation of Viyash is $249.09M as of Jul 2021.